Trending Now
Royalty Pharma plc (RPRX): A Strategic Investment in Life-Changing Therapies
Royalty Pharma plc (Nasdaq: RPRX) closed December 27 at $25.54, up 0.55% for the day, with after-hours trading slightly declining to $25.50....
DIH Holding US, Inc. (DHAI): Pioneering Rehabilitation with Cutting-Edge Technology
Let’s talk about something truly inspiring: the future of rehabilitation. On December 23, 2024, DIH Holding US, Inc. (NASDAQ: DHAI) announced...
Predictive Oncology Inc. (Nasdaq: POAI): A Transformative Acquisition by Renovaro Inc.
The biotechnological domain is currently abuzz with developments surrounding the acquisition of Predictive Oncology Inc. (Nasdaq: POAI) by Renovaro Inc. (Nasdaq: RENB)....
Popular News
The Launch of ImmuneSense Lyme™, a Research by Adaptive Biotechnologies Corp...
Adaptive Biotechnologies Corp (NASDAQ:ADPT) has launched a research study, which will explore Lyme disease in its early stages of an infection. The study ImmuneSense...
MAKE IT MODERN
LATEST REVIEWS
Is a Bottom in Sight for CytoDyn Inc (OTCMKTS:CYDY)?
CytoDyn Inc (OTCMKTS:CYDY) just announced that a research paper entitled "Leronlimab (PRO 140) activity against 4-class drug resistant HIV-1 from Heavily Treatment...
MAKE IT MODERN
PERFORMANCE TRAINING
Cybin Inc. (NYSEAMERICAN: CYBN) Announces Second Quarter Results and Preclinical Data on CYB003
Cybin Inc. (NYSEAMERICAN: CYBN) has announced its unaudited financial results and business updates for the second quarter ended September 30, 2021.
Cybin released CTB003 preclinical...
Cassava Sciences Inc (NASDAQ: SAVA) Announces Positive Data in Alzheimer’s Disease
Cassava Sciences Inc (NASDAQ: SAVA) aims to find and develop unique treatments for Chronic, neurodegenerative conditions. The company announced the positive Biomarker and Cognition...
AVEO Oncology (NASDAQ:AVEO) Announce Publication Of Phase 3 TIVO-3 Study Data In European Urology...
AVEO Oncology (NASDAQ:AVEO) has announced the final overall survival data from the Phase 3 TIVO-3 Study in the European Urology journal.
AVEO publishes TIVI-3 study...
BioNTech (NASDAQ:BNTX) And Pfizer Inc. (NYSE:PFE) Announce Commencement Of EMA Rolling Review On BNT162b2
BioNTech (NASDAQ:BNTX) and Pfizer Inc. (NYSE:PFE) have announced that the European Medicines Agency (EMA) has commenced a rolling review for their leading COVID-19 vaccine...
Plus Therapeutics Inc (NASDAQ: PSTV) Expands its Partnership With Medidata
Plus Therapeutics Inc (NASDAQ: PSTV) and Medidata have expanded their partnership to increase patient recruitment, enhance their access to the therapy, and lower the...
MAKE IT MODERN
